DUBE ERIC M (Chief Executive Officer) sold 4.9% of their position (22.50K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $988.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/7/2026ACC: 0001763494-26-000006
DirectorOfficer· Chief Executive Officer
Since Jan 2019
+22.50K
Net shares
Net buyer
$988.9K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
67.50K acquired · 45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22.50K
Price / share
—
Trade value
—
% of position
5.2%
5/4/2026
432.89K→455.39K
Common Stock
Direct
Shares
−22.50K
Price / share
$43.95
Trade value
$988.88K
% of position
4.9%
5/6/2026
455.39K→432.89K
Total
Net shares
+0.00
Net value
-$988.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | M · Option Exercise | +22.50K | — | — | 5.2% | 432.89K | 455.39K |
| Common Stock Direct | 5/6/2026 | S · Sale | −22.50K | $43.95 | $988.88K | 4.9% | 455.39K | 432.89K |
| Total | +0.00 | -$988.88K | ||||||
Derivative Transactions2
Performance-based restricted stock units
Direct
Converts to
Common Stock
45K shares
Shares
+45K
Strike price
Held after
45K
Exercisable
—
5/4/2026
Performance-based restricted stock units
Direct
Converts to
Common Stock
22.50K shares
Shares
−22.50K
Strike price
Held after
22.50K
Exercisable
—
5/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance-based restricted stock units Direct | Common Stock45K shares | 5/4/2026 | A · Award | +45K | — | 45K | |
| Performance-based restricted stock units Direct | Common Stock22.50K shares | 5/4/2026 | M · Option Exercise | −22.50K | — | 22.50K |